Cargando…
New Perspectives on Primary Prophylaxis of Invasive Fungal Infection in Children Undergoing Hematopoietic Stem Cell Transplantation: A 10-Year Retrospective Cohort Study
SIMPLE SUMMARY: In children undergoing allogenic HCT, invasive fungal infections are a significant cause of mortality, for which ECIL-8 have proposed systematic primary prophylaxis. This study evaluates our local strategy of not systematizing it, and reveals a similar IFI incidence and mortality rat...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093632/ https://www.ncbi.nlm.nih.gov/pubmed/37046769 http://dx.doi.org/10.3390/cancers15072107 |
_version_ | 1785023633020682240 |
---|---|
author | Ricard, Noémi Zebali, Lelia Renard, Cécile Goutagny, Marie-Pierre Benezech, Sarah Bertrand, Yves Philippe, Michael Domenech, Carine |
author_facet | Ricard, Noémi Zebali, Lelia Renard, Cécile Goutagny, Marie-Pierre Benezech, Sarah Bertrand, Yves Philippe, Michael Domenech, Carine |
author_sort | Ricard, Noémi |
collection | PubMed |
description | SIMPLE SUMMARY: In children undergoing allogenic HCT, invasive fungal infections are a significant cause of mortality, for which ECIL-8 have proposed systematic primary prophylaxis. This study evaluates our local strategy of not systematizing it, and reveals a similar IFI incidence and mortality rate. ABSTRACT: Background: Allogenic hematopoietic stem cell transplantation (a-HCT) remains a therapeutic treatment for many pediatric hematological diseases. The occurrence of invasive fungal infections (IFIs) is a complication for which ECIL-8 recommends primary antifungal prophylaxis. In this study, we evaluated the impact of our local strategy of not systematically administering primary antifungal prophylaxis in children undergoing a-HCT on the occurrence and mortality of IFIs. Methods: We performed a retrospective monocentric study from 2010 to 2020. We retained all proven and probable IFIs diagnosed during the first year post a-HCT. Results: 308 patients were included. Eighteen patients developed twenty IFIs (thirteen proven, seven probable) (6.5%) among which aspergillosis (n = 10, 50%) and candidosis (n = 7, 35%) were the most frequently diagnosed infections. Only 2% of children died because of an IFI, which represents 14% of all deaths. Multivariate analysis found that age > 10 years (OR: 0.29), the use of a therapeutic antiviral treatment (OR: 2.71) and a low neutrophil count reconstitution (OR: 0.93) were significantly associated with the risk of IFI occurrence. There was also a trend of malignant underlying disease and status ≥ CR2 but it was not retained in multivariate analysis. Conclusions: IFI occurrence was not higher in our cohort than what is reported in the literature with the use of systematic antifungal prophylaxis, with a good survival rate nonetheless. Thus, a prophylaxis could be considered for children with a high risk of IFI such as those aged over 10 years. |
format | Online Article Text |
id | pubmed-10093632 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100936322023-04-13 New Perspectives on Primary Prophylaxis of Invasive Fungal Infection in Children Undergoing Hematopoietic Stem Cell Transplantation: A 10-Year Retrospective Cohort Study Ricard, Noémi Zebali, Lelia Renard, Cécile Goutagny, Marie-Pierre Benezech, Sarah Bertrand, Yves Philippe, Michael Domenech, Carine Cancers (Basel) Article SIMPLE SUMMARY: In children undergoing allogenic HCT, invasive fungal infections are a significant cause of mortality, for which ECIL-8 have proposed systematic primary prophylaxis. This study evaluates our local strategy of not systematizing it, and reveals a similar IFI incidence and mortality rate. ABSTRACT: Background: Allogenic hematopoietic stem cell transplantation (a-HCT) remains a therapeutic treatment for many pediatric hematological diseases. The occurrence of invasive fungal infections (IFIs) is a complication for which ECIL-8 recommends primary antifungal prophylaxis. In this study, we evaluated the impact of our local strategy of not systematically administering primary antifungal prophylaxis in children undergoing a-HCT on the occurrence and mortality of IFIs. Methods: We performed a retrospective monocentric study from 2010 to 2020. We retained all proven and probable IFIs diagnosed during the first year post a-HCT. Results: 308 patients were included. Eighteen patients developed twenty IFIs (thirteen proven, seven probable) (6.5%) among which aspergillosis (n = 10, 50%) and candidosis (n = 7, 35%) were the most frequently diagnosed infections. Only 2% of children died because of an IFI, which represents 14% of all deaths. Multivariate analysis found that age > 10 years (OR: 0.29), the use of a therapeutic antiviral treatment (OR: 2.71) and a low neutrophil count reconstitution (OR: 0.93) were significantly associated with the risk of IFI occurrence. There was also a trend of malignant underlying disease and status ≥ CR2 but it was not retained in multivariate analysis. Conclusions: IFI occurrence was not higher in our cohort than what is reported in the literature with the use of systematic antifungal prophylaxis, with a good survival rate nonetheless. Thus, a prophylaxis could be considered for children with a high risk of IFI such as those aged over 10 years. MDPI 2023-03-31 /pmc/articles/PMC10093632/ /pubmed/37046769 http://dx.doi.org/10.3390/cancers15072107 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ricard, Noémi Zebali, Lelia Renard, Cécile Goutagny, Marie-Pierre Benezech, Sarah Bertrand, Yves Philippe, Michael Domenech, Carine New Perspectives on Primary Prophylaxis of Invasive Fungal Infection in Children Undergoing Hematopoietic Stem Cell Transplantation: A 10-Year Retrospective Cohort Study |
title | New Perspectives on Primary Prophylaxis of Invasive Fungal Infection in Children Undergoing Hematopoietic Stem Cell Transplantation: A 10-Year Retrospective Cohort Study |
title_full | New Perspectives on Primary Prophylaxis of Invasive Fungal Infection in Children Undergoing Hematopoietic Stem Cell Transplantation: A 10-Year Retrospective Cohort Study |
title_fullStr | New Perspectives on Primary Prophylaxis of Invasive Fungal Infection in Children Undergoing Hematopoietic Stem Cell Transplantation: A 10-Year Retrospective Cohort Study |
title_full_unstemmed | New Perspectives on Primary Prophylaxis of Invasive Fungal Infection in Children Undergoing Hematopoietic Stem Cell Transplantation: A 10-Year Retrospective Cohort Study |
title_short | New Perspectives on Primary Prophylaxis of Invasive Fungal Infection in Children Undergoing Hematopoietic Stem Cell Transplantation: A 10-Year Retrospective Cohort Study |
title_sort | new perspectives on primary prophylaxis of invasive fungal infection in children undergoing hematopoietic stem cell transplantation: a 10-year retrospective cohort study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093632/ https://www.ncbi.nlm.nih.gov/pubmed/37046769 http://dx.doi.org/10.3390/cancers15072107 |
work_keys_str_mv | AT ricardnoemi newperspectivesonprimaryprophylaxisofinvasivefungalinfectioninchildrenundergoinghematopoieticstemcelltransplantationa10yearretrospectivecohortstudy AT zebalilelia newperspectivesonprimaryprophylaxisofinvasivefungalinfectioninchildrenundergoinghematopoieticstemcelltransplantationa10yearretrospectivecohortstudy AT renardcecile newperspectivesonprimaryprophylaxisofinvasivefungalinfectioninchildrenundergoinghematopoieticstemcelltransplantationa10yearretrospectivecohortstudy AT goutagnymariepierre newperspectivesonprimaryprophylaxisofinvasivefungalinfectioninchildrenundergoinghematopoieticstemcelltransplantationa10yearretrospectivecohortstudy AT benezechsarah newperspectivesonprimaryprophylaxisofinvasivefungalinfectioninchildrenundergoinghematopoieticstemcelltransplantationa10yearretrospectivecohortstudy AT bertrandyves newperspectivesonprimaryprophylaxisofinvasivefungalinfectioninchildrenundergoinghematopoieticstemcelltransplantationa10yearretrospectivecohortstudy AT philippemichael newperspectivesonprimaryprophylaxisofinvasivefungalinfectioninchildrenundergoinghematopoieticstemcelltransplantationa10yearretrospectivecohortstudy AT domenechcarine newperspectivesonprimaryprophylaxisofinvasivefungalinfectioninchildrenundergoinghematopoieticstemcelltransplantationa10yearretrospectivecohortstudy |